Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic

Beach, T. G., Monsell, S. E., Phillips, L. E. & Kukull, W. Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010. J. Neuropathol. Exp. Neurol. 71, 266–273 (2012).

Morris, J. C. et al. Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease. Arch. Neurol. 58, 124–129 (2001).

Bondi, M. W. et al. Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates. J. Alzheimers. Dis. 42, 275–289 (2014).

Petersen, R. C. et al. Mild cognitive impairment: A concept in evolution. J. Intern. Med. 275, 214–228 (2014).

Espinosa, A. et al. A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved. J. Alzheimers. Dis. 34, 769–780…